Research

Research in the department of pharmaceutics encompasses studies in pharmacokinetics, quantitative pharmacology, pharmacometrics, pharmaceutical analysis, pharmaceutical biotechnology and drug delivery.

cancer therapy

Thomas Schmittgen

Dr. Schmittgen’s research interests include cancer therapeutics, exosomes as targeted drug delivery systems and the role of noncoding RNAs in cancer initiation and progression.

Schmittgen Slider

translational systems pharmacology and pharmacometrics

Sihem Bihorel

Dr. Bihorel’s research interests include leading-edge experimental and computational techniques to rationally optimize sequence combination therapies of anti-cancer drugs; bench-to-bedside, multiscale, system-based PK/PD models in oncology; novel nanodelivery system development for cancer therapy.

Bihorel

Pharmacokinetics of Inhaled glucocorticoids

Guenther Hochhaus

Dr. Hochhaus’ research interests include the relationship between the drug and formulation properties of inhalation drugs, their pharmacokinetic and dynamic properties, and bioequivalence pharmacodynamic effects.

Guenther Hochhaus

optimizing pharmacy education

William Cary Mobley

Dr. Mobley’s Research interests include application of instructional design principles to optimize student pharmacist learning and the application of critical thinking and reasoning skills to help develop problem-solving abilities.

Cary Mobley

Pharmacometrics and systems pharmacology

Stephan Schmidt

Dr. Schmidt’s research interests include the application of quantitative analysis tools to address clinically relevant research questions in the areas of antimicrobial chemotherapy, pediatrics, diabetes, cardiovascular safety and postmenopausal osteoporosis.

Stephan Schmidt

Gene and stem cell therapy

Sihong Song

Dr. Song’s research interests include adeno-associated virus, or AAV, vector biology, liver and muscle gene delivery, novel function of alpha 1 antitrypsin, or AAT, AAT deficiency and autoimmune and inflammatory diseases.

Sonal Song

Pharmacometrics

Valvanera Vozmediano

Dr. Vozmediano’s research interests include model-informed drug development for strategic decision making in special populations, implementation of pharmacometric-based regulatory strategies, and application of translational research to animal health.

Vozmediano

2018-19 research funding

$6.2 million

Faculty in the department of pharmaceutics secured $6.2 million in research funding in 2018.

Stephan Schmidt, Ph.D., and his research team use computer simulation models to study drug interactions.

Established in 2011

Center for Pharmacometrics and Systems Pharmacology

Creating a uniquely rigorous and integrative academic translational science program in quantitative clinical pharmacology with a focus on precision medicine.

CPSP